Pratibha Srivastava
Children's Hospital of Philadelphia, University of Pennsylvania
About
Pratibha Srivastava is a molecular biologist specializing in the development of therapeutic pancreatic beta cells with enhanced robustness and functionality. Utilizing cutting-edge CRISPR gene editing technology, Pratibha engineers have induced pluripotent stem cell (iPSC) lines to create next-generation beta cells, aiming to revolutionize treatments for Diabetes. Their work focuses on improving the viability and performance of these cells, addressing critical challenges in regenerative medicine and cell therapy. With a deep commitment to advancing translational science, Pratibha contributes to the growing field of precision medicine by bridging molecular biology, stem cell technology, and genome engineering.
Employment
-
Children's Hospital of Philadelphia Postdoctoral Researcher2023 - Present
-
University of Pennsylvania PostDoctoral Researcher2022 - 2023
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- The Mediator subunit <scp>MED12</scp> promotes formation of <scp>HSF1</scp> condensates on heat shock response element arrays in heat‐shocked cells Save
- MED12 interacts with the heat‐shock transcription factor HSF1 and recruits CDK8 to promote the heat‐shock response in mammalian cells Save
- HSF1 is required for induction of mitochondrial chaperones during the mitochondrial unfolded protein response Save
- The pericentromeric protein shugoshin 2 cooperates with HSF 1 in heat shock response and RNA Pol II recruitment Save
- Differential Proteome Analysis of Chikungunya Virus and Dengue Virus Coinfection in Aedes Mosquitoes Save
- Poly(ADP-Ribose) Polymerase 1 Promotes the Human Heat Shock Response by Facilitating Heat Shock Transcription Factor 1 Binding to DNA Save
- Translationally controlled tumor protein (TCTP) is required for TGF-β1 induced epithelial to mesenchymal transition and influences cytoskeletal reorganization Save
- Transcriptome analysis of Aedes aegypti in response to mono-infections and co-infections of dengue virus-2 and chikungunya virus Save